Jiyang Yu

28PUBLICATIONS
218CO-AUTHORS
Haematological tumoursMolecular targetsProteomics and intermolecular interactions (excl. medical proteomics)Gene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Apr 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.

|Feb 27, 2026
Antigen Specificity and Cell Engineering Determine CAR T Cell Efficacy in Group 3 Medulloblastoma.

Giedre Krenciute, Meghan Ward, Justine Fouliard

|Feb 12, 2026
Cell type-resolved proteomics reveals intra- and intercellular signaling in Alzheimer's disease.

Xue Zhang, Kaiwen Yu, Him K Shrestha

|Jan 23, 2026
DHODH as a targetable metabolic Achilles' heel for chemotherapy-resistant B-ALL.

Yuxuan Liu, Haowen Jiang, Jingjing Liu

|Dec 03, 2025
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastoma.

Jingjing Liu, Xu Yang, Mingrui Zhu

|Sep 10, 2025
Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cells.

Kelly McCastlain, Catherine Welsh, Yonghui Ni

Pageof 5

Frequent Collaborators

7 joint publications

Yizhen Li

7 joint publications

Wenjian Yang

5 joint publications

Marina Y Konopleva

5 joint publications

Jingjing Liu